Cancer marker tests

It is used to diagnose and monitor the effectiveness of treatment in ovarian cancer.

It is used to diagnose and monitor the effectiveness of treatment in breast cancer.

CA 19-9 has a clinical sensitivity of 70-80% for pancreatic cancer. Evaluated together with CEA as a secondary marker for gallbladder, colon and stomach cancer; for liver metastases.

The best laboratory indicator for gastric cancer. Blood levels of the indicator are monitored to track the progress of gastric cancer

The most important test is to diagnose the prostate carriage and monitor treatment. It is also used for preventive screening of men over 30 years of age for the early diagnosis of prostate cancer.

This indicator is used to investigate two groups of pathologies: 1.cancers; 2.foetal malformations.